JP2024509820A5 - - Google Patents
Info
- Publication number
- JP2024509820A5 JP2024509820A5 JP2023553194A JP2023553194A JP2024509820A5 JP 2024509820 A5 JP2024509820 A5 JP 2024509820A5 JP 2023553194 A JP2023553194 A JP 2023553194A JP 2023553194 A JP2023553194 A JP 2023553194A JP 2024509820 A5 JP2024509820 A5 JP 2024509820A5
- Authority
- JP
- Japan
- Prior art keywords
- cannabinoid
- sulfate
- glucosamine
- formula
- cbd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163155949P | 2021-03-03 | 2021-03-03 | |
| US63/155,949 | 2021-03-03 | ||
| PCT/CA2022/050304 WO2022183292A1 (en) | 2021-03-03 | 2022-03-03 | Synergistic cannabinoid esters, their salts and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024509820A JP2024509820A (ja) | 2024-03-05 |
| JP2024509820A5 true JP2024509820A5 (cg-RX-API-DMAC7.html) | 2025-03-10 |
Family
ID=83153828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023553194A Pending JP2024509820A (ja) | 2021-03-03 | 2022-03-03 | 相乗的カンナビノイドエステル、その塩及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240189327A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4301762A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024509820A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230155491A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116964064A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022229038A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3210762A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL305566A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023010162A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022183292A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3227884A1 (en) | 2021-08-04 | 2023-02-09 | John Crawford | Cannabinoid derivatives and their use |
| US20250019345A1 (en) * | 2021-11-10 | 2025-01-16 | London Pharmaceuticals And Research Corporation | New cannabinoid-gabapentinoid conjugates and uses thereof |
| WO2023168023A1 (en) | 2022-03-04 | 2023-09-07 | Reset Pharmaceuticals, Inc. | Co-crystals or salts comprising psilocin |
| KR20240150100A (ko) * | 2023-04-07 | 2024-10-15 | 주식회사 네오켄바이오 | 칸나비오르콜 또는 이의 유도체를 유효성분으로 포함하는 염증성 질환의 예방 또는 치료용 약학적 조성물 |
| US20240342250A1 (en) * | 2023-04-12 | 2024-10-17 | Xygenyx Inc. | Composition and methods of treatment using synergistically-enhanced supplementation |
| CN120289405A (zh) * | 2025-04-03 | 2025-07-11 | 江苏海洋大学 | 一种卡利拉嗪和槲皮素药物共晶及其制备方法与应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009073633A1 (en) * | 2007-11-30 | 2009-06-11 | Alltranz Inc. | Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same |
| JP2019523228A (ja) * | 2016-06-16 | 2019-08-22 | ティーウィノット テクノロジーズ リミテッド | カンナビノイドプロドラッグの製造のための方法、薬学的製剤、およびその使用 |
| WO2018096504A1 (en) * | 2016-11-28 | 2018-05-31 | Kalytera Therapeutics, Inc | Cbd prodrugs, compositions, and methods of administering cbd and cbd prodrugs |
| CA3079537A1 (en) * | 2017-09-02 | 2019-03-07 | Scientific Holdings, Llc | Tetrahydrocannabinol modulators |
| MX2022009507A (es) * | 2020-02-06 | 2022-11-09 | London Pharmaceuticals And Res Corporation | Ésteres de sulfato de cannabinoides, sus sales y usos de los mismos. |
-
2022
- 2022-03-03 US US18/279,974 patent/US20240189327A1/en active Pending
- 2022-03-03 WO PCT/CA2022/050304 patent/WO2022183292A1/en not_active Ceased
- 2022-03-03 EP EP22762294.1A patent/EP4301762A4/en active Pending
- 2022-03-03 AU AU2022229038A patent/AU2022229038A1/en active Pending
- 2022-03-03 KR KR1020237033380A patent/KR20230155491A/ko active Pending
- 2022-03-03 JP JP2023553194A patent/JP2024509820A/ja active Pending
- 2022-03-03 CA CA3210762A patent/CA3210762A1/en active Pending
- 2022-03-03 MX MX2023010162A patent/MX2023010162A/es unknown
- 2022-03-03 IL IL305566A patent/IL305566A/en unknown
- 2022-03-03 CN CN202280019080.8A patent/CN116964064A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024509820A5 (cg-RX-API-DMAC7.html) | ||
| TWI761476B (zh) | 尼拉帕尼(niraparib)組合物 | |
| KR100198044B1 (ko) | 이부프로펜 염을 포함하는 약제학적 조성물 | |
| MXPA01007350A (es) | Derivados anticonvulsivos utiles en el tratamiento de cefalea acuminada. | |
| US8598225B2 (en) | Use of L-butylphthalide in the manufacture of medicaments for treatment of cerebral infarct | |
| EP3890726A1 (en) | Methods of treating neurological and psychiatric disorders | |
| RU2017115925A (ru) | Сокристаллы модуляторов регулятора трансмембранной проводимости при кистозном фиброзе | |
| US20090088404A1 (en) | Extended Release Pharmaceutical Formulations of S-Adenosylmethionine | |
| JP2015091822A5 (cg-RX-API-DMAC7.html) | ||
| JP2003521471A (ja) | 慢性神経変性疾患を処置することに有用な抗痙攣薬誘導体 | |
| JP7051133B2 (ja) | 口内乾燥症（ｘｅｒｏｓｔｏｍｉａ）の治療のための組成物および方法 | |
| WO2012000377A1 (zh) | 包含左卡尼汀和羟苯磺酸盐的药物组合物 | |
| JP2015180673A (ja) | トランスノルセルトラリン及びセロトニン受容体１ａ作動剤／拮抗剤を含む組成物及びその使用 | |
| JP2024509820A (ja) | 相乗的カンナビノイドエステル、その塩及びその使用 | |
| JP2026021312A (ja) | フェニルスルホンアミドを含む薬学的組成物、及びそれらの治療的適用 | |
| WO1998000124A1 (en) | Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of postischemic neurodegeneration | |
| KR20180059390A (ko) | 근육통과 관련된 상태의 치료를 위한 배합물 | |
| JP7417595B2 (ja) | てんかん重積状態の予防、軽減又は治療のためのカルバメート化合物の使用 | |
| EP3028706A1 (en) | Pharmaceutical composition with antiinflammatory agents and production process | |
| JP4913359B2 (ja) | イブプロフェン含有医薬組成物 | |
| JP2024524572A5 (cg-RX-API-DMAC7.html) | ||
| CN105330708B (zh) | 延胡索乙素衍生物及其制备方法、用途 | |
| EP0542632A1 (fr) | Utilisation du beta-carotène dans le traitement de fond de l'asthme | |
| WO2016114734A1 (en) | Pharmaceutical formulation of trimebutine maleate and simethicone comprising acidifying agent | |
| WO2024194891A1 (en) | Novel phosphate compounds and process for preparation thereof |